Adrenomedullin (AM) is a hypotensive peptide progene in type 2 diabetic patients with renal failure.
tide widely produced in the cardiovascular organs and tissues tor action, AM has also been shown to cause natriuresis such as the heart, kidney, and the vascular cells. We have prein the kidney [3] . A significant level of AM has been also viously cloned and sequenced the genomic DNA encoding human AM gene, and determined that the gene is located in the identified in human plasma [1, 4] and we have previously short arm of chromosome 11. The 3Ј-end of the gene is flanked reported that plasma AM levels are increased in patients by the microsatellite marker of cytosine adenine (CA) repeats.
with renal failure and hypertension [5] . Moreover, it has In this study, we investigated the association between DNA been recently reported that gene delivery or chronic variations in AM gene and the predisposition to develop neadministration of AM alleviates renal injuries in hyperphropathy in type 2 diabetes mellitus.
Methods. Genomic DNA was obtained from the peripheral tensive rats [6] [7] [8] [9] [10] . These findings suggest that AM has leukocytes of 233 normal healthy subjects (NH), 139 type 2 implications in pathophysiology of the renal diseases.
diabetic patients on hemodialysis (DM-HD), 106 control pa-
We have cloned and sequenced the genomic DNA tients with type 2 diabetes without nephropathy (DM-C) and encoding human AM gene, and determined that the gene 318 hemodialysis patients due to chronic glomerulonephritis is located in the short arm of chromosome 11 [11] . The (CGN-HD). The genomic DNA was subject to polymerase chain gene consists of four exons and whole nucleotide sereaction (PCR) using a fluorescence-labeled primer, and the number of CA repeats were determined by polyacrylamide gel quence corresponding to the 52 amino acid residues of electrophoresis (PAGE).
mature AM is included in the fourth exon. Nucleotide
Results. In our Japanese subjects, there existed four types sequencing of genomic DNA adjacent to the AM gene of alleles with different CA-repeat number; 11, 13, 14, and 19. revealed that the 3Ј-end of the gene is flanked by the The frequencies of these alleles were 11: 27.7%, 13: 32.8%, 14: microsatellite marker with a variable number of cytosine 35 .6%, and 19: 3.9% in NH. These allele frequencies were not significantly different in DM-C and CGN-HD. However, adenine (CA) repeat [12] . This microsatellite marker is DM-HD showed significantly different distribution of allele located approximately 4 kb downstream of the AM gene.
frequency from other groups ( 2 ϭ 18.9, P ϭ 0.026). Namely, Considering the possible implications of AM in the carthe frequency of 19-repeat allele in DM-HD was higher (9.0%) diovascular system, it seems of interest to elucidate than NH, DM-C, and CGN-HD (P ϭ 0.005, 0.041, and 0.004, whether this gene variation has any relation to the etiolrespectively thy, not only type 1 but also type 2, occurs in familial clusters, suggesting that genetic factors may be involved in the pathogenesis [13, 14] . In this aspect, numbers of studies have been performed as to the association of various gene polymorphisms with genetic susceptibility METHODS was performed with 0.5 g of genomic DNA and 25 pmol of each primer (sense 5Ј-AAGAGGCTGAGTCAGAA Study subjects GGATTGG-3Ј and antisense 5Ј-GCAACATCATTTT A group of 139 hemodialysis patients with type 2 dia-AATATCCTGCACAG-3Ј) in a final volume of 50 L betes (DM-HD) were selected from the hemodialysis containing 10 mmol/L Tris-HCl (pH 8.3), 50 mmol/L unit of Dokkyo University School of Medicine Hospital KCl, 1.5 mmol/L MgCl 2 , 10 g/mL gelatin, 0.2 mmol/L and eight nearby hemodialysis hospitals and clinics.
of each deoxynucleoside triphosphate (dNTP), 1 unit of Type 2 diabetes was diagnosed when diabetes was de-Taq DNA polymerase (Perkin-Elmer, Branchburg, New tected at 30 years old or older and insulin therapy was Jersey). The 5Ј end of sense primer was labeled with the not given during 2 years after the onset [15] . From the blue fluorescent dye 6-FAM. The DNA was amplified same hospitals and clinics, 318 hemodialysis patients due for 30 cycles with denaturation at 94ЊC for 45 seconds, to chronic glomerulonephritis (CGN-HD) were involved annealing at 60ЊC for 1 minute, and extension at 72ЊC in this study. Glomerulonephritis was diagnosed by prefor 2 minutes in a thermal cycler. Then, an aliquot of the vious renal biopsy or the presence of 2ϩ or more protein-PCR product was mixed with the internal DNA size uria and hematuria and exclusion of other renal diseases standard labeled with the red fluorescent dye ROX. The such as diabetic nephropathy, hypertensive nephroscleromixture was electrophoresed on a 6% urea-polyacrylsis, lupus nephritis, polycystic kidney, and pyelonephritis.
amide gel using ABI 373 DNA sequencer (Perkin-Elmer). A hundred and six control type 2 diabetes patients without
The length of PCR product was calculated from the calinephropathy (DM-C) were selected from the outpatient bration curve of internal standard using GENESCAN clinic of Dokkyo University School of Medicine Hospi-672 software (Perkin-Elmer). tal. In addition to the criteria for the diagnosis of type 2 diabetes, three more criteria were applied to select DM-C Biochemical measurement subjects: (1) normal serum creatinine (men Ͻ1.5 mg/dL Peripheral blood sample was obtained in the morning and women Ͻ1.3 mg/dL), (2) absence of microalbuminafter overnight fast in NH and DM-C. In DM-HD and uria, and (3) 5 or more years of known history of diabetes.
CGN-HD, blood sample was taken before hemodialysis. Microalbuminuria was denied when the albumin in spot Serum creatinine was measured by automatic analyzer urine was less than 30 mg/g creatinine on multiple occa-(HITACHI 736-60; Hitachi, Tokyo, Japan) and blood sions [16] . The normal healthy group (NH) included 233 hemoglobin A 1c was determined by high-performance healthy subjects age 50 years old or older. They were reliquid chromatography (HPLC) using ADAMS hemocruited from participants of the health check program globin A 1c HA-8160 (ARKRAY, Inc., Kyoto, Japan). of Dokkyo University School of Medicine Hospital. Diseases were ruled out through comprehensive checkup, in-Statistical analysis cluding a full medical history taking and physical exami-Data are presented as means Ϯ SD. Statistical analyses nations, urinalysis, a stool examination, blood cell counts, were performed using Stat View software (version 5.0; blood chemistry, a glucose tolerance test, serologic tests SAS Institute Inc., Cary, NC, USA). Clinical characterisfor hepatitis viruses, a chest x-ray film, an electrocardiotics between the case and control groups were compared gram, a respiratory function, an alimentary examination by one-way analysis of variance (ANOVA) for parametof the upper gastrointestinal tract, and abdominal ultraric data and by chi-square test for categoric data. If the sonography. The physical examination was performed by ANOVA showed statistical significance, Scheffe's test an internist, a surgeon, an ophthalmologist, an otorhinowas applied for the post-hoc comparison between groups. laryngologist, and a gynecologist for women. All subjects
The frequencies of alleles and genotypes in the four were Japanese and unrelated each other. groups were compared by chi-square test and Fisher's The study protocol was approved by the Institutional exact test. Differences of parametric data in two groups Ethical Committee, and informed consent was obtained were analyzed by unpaired Student t test. A P value less from each subject. than 0.05 was considered to indicate statistical significance.
Genotype analysis
The number of CA repeats adjacent to AM gene was RESULTS determined by fluorescence-labeled polymerase chain Clinical characteristics of study subjects reaction and polyacrylamide gel electrophoresis (PCR-PAGE) as described previously [12, 17] . Genomic DNA Table 1 lists the physical and laboratory findings of was extracted from peripheral leukocytes using Easy the study subjects. Average age and the gender ratio DNA kit (Invitrogen, Carlsbad, CA, USA). The microwere not significantly different among the four groups. satellite region containing the CA repeats 4 kb down-Body mass index was greater in DM-C than in NH (P ϭ 0.026). However, the body mass index of DM-HD was stream of the AM gene was amplified by PCR. The PCR Abbreviations are: NH, normal healthy subjects; DM-C, control diabetic patients without nephropathy; DM-HD, diabetic patients on hemodialysis; CGN-HD, hemodialysis patients due to chronic glomerulonephritis. Data are mean Ϯ SD. F values of ANOVA for body mass index, systolic blood pressure, diastolic blood pressure, and serum creatinine are 72.0 (P Ͻ 0.001), 250.4 (P Ͻ 0.001), 48.7 (P Ͻ 0.001), and 1422.8 (P Ͻ 0.001), respectively. a P Ͻ 0.01; b P Ͻ 0.001 vs. NH; c P Ͻ 0.01; d P Ͻ 0.001 vs. DM-C; and e P Ͻ 0.001 vs. CGN-HD Table 3 . Allele frequencies of microsatellite DNA polymorphism Table 2 . Genotype frequencies of microsatellite DNA polymorphism adjacent to the human adrenomedullin adjacent to the human adrenomedullin gene in the study subjects gene in the study subjects Table 2 shows smaller than that of NH and comparable to that of observed frequencies of these ten genotypes of this mi-CGN-HD. Systolic and diastolic blood pressures were crosatellite gene polymorphism in the study subjects, and obviously higher in DM-C, DM-HD, and CGN-HD than Table 3 lists the frequency of each allele calculated from in NH (P Ͻ 0.001, respectively). Especially, DM-HD the genotype frequencies. The genotype frequencies were had even higher systolic blood pressure than DM-C and not significantly deviated from those expected from the CGN-HD (P Ͻ 0.001, respectively), and DM-C had Hardy-Weinberg's equilibrium in each group. The frehigher diastolic pressure than DM-HD (P ϭ 0.007) and quencies of 11, 13, and 14, repeat alleles were approxi-CGN-HD (P ϭ 0.008). Duration of diabetes was compamately 30%, while the frequency of 19 repeat allele was rable between DM-C and DM-HD, however, the duraless than 10% in each group. There were no homozygotes tion of diabetes in DM-C was longer than the duration of the least frequent 19 repeat allele in the examined of diabetes until nephropathy was revealed in DM-HD, subjects. Distributions of the genotypes were not signifi-P Ͻ 0.001. In hemodialysis patients, DM-HD had shorter cantly different among the four groups. On the other hand, duration of dialysis than CGN-HD, P Ͻ 0.001. Serum creatinine did not significantly differ between NH and the allele frequencies were significantly different between DM-C. Of course, DM-HD and CGN-HD had much the groups ( 2 ϭ 18.9, P ϭ 0.026). Figure 1 depicts the difhigher serum creatinine than NH and DM-C (P Ͻ 0.001, ference in allele frequency more clearly. The frequency respectively). In hemodialysis patients, predialysis serum of 19 repeat allele was higher in DM-HD than in NH, creatinine was lower in DM-HD than in CGN-HD, P Ͻ DM-C, or CGN-HD. The frequencies of 11, 13, and 14 0.001. Blood hemoglobin A 1c was lower in DM-HD than repeat alleles did not show significant group differences. in DM-C, P Ͻ 0.001.
DISCUSSION

Genotype and allele frequencies
Nowadays, diabetic nephropathy is the leading cause As we have reported previously [12, 17] , there existed four types of alleles with different CA repeat number; of end-stage renal failure in Japan as well as in United DNA polymorphism adjacent to the AM gene with the genetic predisposition to suffer diabetic nephropathy. Namely, the existence of 19 CA repeat allele is supposed to be associated with the risk of developing nephropathy in Japanese type 2 diabetic patients. However, because the frequency of this 19 repeat allele was small, this gene variation alone is not thought to reflect the large part of genetic predisposition to diabetic nephropathy. Any single gene polymorphism, which has been previously shown to be associated with diabetic nephropathy, does not represent the large part of genetic risk for diabetic nephropathy. It is supposed that multiple genes contribute to the development of diabetic nephropathy. In the future direction, information as to the relation between gene polymorphisms and the risk of diabetic nephropathy should be gathered and analyzed comprehensively Fig. 1. Frequencies of 11, 13, 14, and 19 phism examined in this study seems to add information to the prediction of the development of diabetic nephropathy. Some gene polymorphisms have been shown to affect States and European countries. Because type 2 diabetes expression of the genes or activity of the gene products. is much more frequent than type 1 diabetes in Japan, For instance, the serum ACE activity is known to be prevention of nephropathy in type 2 diabetic patients is increased in individuals carrying the deletion allele of of primary importance. In order to reduce the incidence the gene [28] , and it has been reported that the methioof diabetic nephropathy effectively, it is necessary to nine to threonine substitution at amino acid residue 235 identify the patients at high risk. It is known that the (M235T) of angiotensinogen is associated with an ininfluence of a genetic factor on the onset of diabetes is crease in the gene expression [29] . Because the microgreater in type 2 diabetes than in type 1 diabetes. Alsatellite polymorphism examined in this study is located though the familial clustering of diabetic nephropathy 3Ј downstream of the AM gene, it is unlikely that the has first been reported in type 1 diabetes [13] , later evigene transcription is affected by this polymorphism. Indence has also indicated inherited susceptibility to nedeed, the plasma AM levels were not significantly differphropathy in type 2 diabetes [14, 18, 19] . In order to ent among the genotypes of this polymorphism in normal delineate the genetic background of type 2 diabetic nesubjects [12] . Namely, the subjects carrying 19 repeat phropathy, numbers of studies have investigated the asallele and the homogygotes of 11, 13, and 14 repeat allele sociation of this complication with various gene polymorshowed comparable plasma AM levels. Therefore, the phisms. So far, several gene polymorphisms have been association of 19 CA repeat allele with diabetic nephropindicated to have relation with the predisposition to deathy is not likely mediated by the gene expression and velop nephropathy in type 2 diabetic patients. The gene the action of AM itself. It may be possible that this polymorphisms include genes of renin-angiotensin sysmicrosatellite polymorphism is associated with the extem such as angiotensin-converting enzyme (ACE) and pression of other genes. Near the location of AM gene angiotensinogen, and genes of endothelial nitric oxide in the short arm of chromosome 11, there exist such synthase, glucose transporter, apolipoprotein E, methylgenes as sphyngomyelinase, parathyroid hormone, and enetetrahydrofolate reductase and G-protein ␤3 subunit [20] [21] [22] [23] [24] [25] [26] [27] .
lactate dehydrogenase [30-32]. Among these, so far the literature does not suggest relation of sphyngomyelinase In the present study, we examined the microsatellite DNA polymorphism lying 3Ј downstream of the AM and lactate dehydrogenase genes to diabetic nephropathy. With regard the parathyroid hormone gene, it has gene in diabetic patients and patients with end-stage renal disease. Among the four types of alleles with CA been shown that the secretion of parathyroid hormone is impaired in patients with diabetic nephropathy [33, 34] , repeat number of 11, 13, 14, and 19, the frequency of 19 repeat allele was higher in DM-HD than in NH, DM-C, which suggests relation between the development of diabetic nephropathy and the expression of parathyroid hor-and CGN-HD. The frequency of 19 repeat allele in DM-HD was more than twice as much as other groups.
mone gene, although this may be caused by the long duration of poor glycemic control as well. Besides these, This result suggests the association of microsatellite the microsatellite polymorphism downstream of AM gene 24-26, 42, 44-46] . In this respect, the subjects of this study are all Japanese and ethnically unanimous. However, may be linked to other yet unidentified gene variations.
Microsatellite markers, like the one examined in this inharmonious results have been sometimes obtained even in the same or the closely related ethnic groups study, consist of variable number of repeats of short nucleotides, and more than hundreds of such repeat [23, 27, 43, 47] . In some studies, microalbuminuria was assumed to indicate the existence of diabetic nephropa-markers are scattered throughout the genomic DNA. These microsatellite markers can be utilized to locate thy. However, it has been reported that type 2 diabetic patients with microalbuminuria have heterogenous renal the genomic region responsible for hereditary diseases or traits. Until now, several diseases have been shown lesions [48] . Therefore, the relations between gene polymorphisms and type 2 diabetic nephropathy may be af-to be associated with such microsatellite DNA polymorphism. For instance, it has been reported that the CA fected by the criteria used for the diagnosis of diabetic nephropathy. repeat polymorphism lying upstream of aldose reductase gene affects the development of nephropathy and reti-
The results of this study revealed the association of the microsatellite CA repeat polymorphism adjacent to nopathy in type 1 diabetes mellitus [35, 36] . However, inconsistent results have been reported as to the associa-the AM gene with genetic predisposition to type 2 diabetic nephropathy in Japanese population. The frequency tion of this microsatellite polymorphism with type 2 diabetic nephropathy [37] [38] [39] . On the other hand, genetic of 19 repeat allele was significantly increased in patients with end-stage renal disease due to type 2 diabetes. Al-predisposition to essential hypertension has been shown to have significant linkage to a certain number of TCAT though this DNA polymorphism is not likely to affect the AM gene transcription, the existence of 19 CA repeat repeat in the intron 1 of tyrosine hydroxylase gene and the GT repeat in the intron 2 of type B natriuretic peptide allele is supposed to reflect a certain part of the genetic predisposition to develop nephropathy in Japanese type receptor gene [40, 41] . We have also reported that the 19 CA repeat allele examined in this study is increased 2 diabetic patients. in patients with essential hypertension [17] . The relation of these microsatellite polymorphisms to diabetic ne-ACKNOWLEDGMENTS phropathy has not yet been examined. However, it seems 
